Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30014306HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30014330HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30010713HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30007991HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30010714HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30007992HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30015925HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30015924HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30012871HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30012872HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TCGA Plot Options
Drug Information
GeneTOP1
DrugBank IDDB12893
Drug NameSacituzumab govitecan
Target IDBE0000971
UniProt IDP11387
Regulation Typeinhibitor
PubMed IDs31415916
CitationsBailly C: Irinotecan: 25 years of cancer treatment. Pharmacol Res. 2019 Oct;148:104398. doi: 10.1016/j.phrs.2019.104398. Epub 2019 Aug 12.
GroupsApproved; Investigational
Direct ClassificationPeptides
SMILES
Pathways
PharmGKB
ChEMBL